Azetidine derivatives as glyt1 inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 213/24 (2006.01) A61K 31/44 (2006.01) A61P 25/00 (2006.01) C07C 13/00 (2006.01) C07D 205/04 (2006.01) C07D 231/24 (2006.01) C07D 239/30 (2006.01) C07D 403/12 (2006.01)

Patent

CA 2630039

The present invention relates to compounds of formula (I); and pharmaceutically acceptable salts thereof and individual enantiomers and diastereomers thereof, as GIyTl inhibitors for treating neurological and psychiatric disorders.

La présente invention concerne des composés de formule I : ,R5 R1 N Il > ^\C / A^ R2 \ / N (A)n, v H / / \ Rb « T Ra ^SO2R3 (I) ainsi que des sels de qualité pharmaceutique desdits composés et des énantiomères et des diastéréoisomères purs desdits composés, en tant qu'inhibiteurs de GlyT1, pour le traitement de troubles neurologiques et psychiatriques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Azetidine derivatives as glyt1 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Azetidine derivatives as glyt1 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azetidine derivatives as glyt1 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2048856

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.